NASDAQ:GRI

GRI Bio (GRI) Stock Price, News & Analysis

0.45
-0.01 (-2.85%)
(As of 04/23/2024 09:04 PM ET)
Today's Range
0.43
0.48
50-Day Range
0.45
1.10
52-Week Range
0.42
93.31
Volume
143,300 shs
Average Volume
616,372 shs
Market Capitalization
$1.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
GRI stock logo

About GRI Bio Stock (NASDAQ:GRI)

GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on treating inflammatory, fibrotic, and autoimmune diseases in the United States. Its product pipeline comprises GRI-0621, which is in phase II clinical development for the treatment of idiopathic pulmonary fibrosis; GRI-0803 which is in phase I trial for the treatment of systematic lupus erythematosus; GRI-0124, which is in pre-clinical development for the treatment of primary sclerosing cholangitis; and GRI-0729 in pre-clinical development. The company also develops ADAIR and ADMIR for treatment of attention -deficit/hyperactivity disorder. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.

GRI Stock Price History

GRI Stock News Headlines

How to camouflage a factory of 53,000 workers
"If I Had To Pour Every Single Penny of My Retirement Into Just ONE STOCK..." The former Goldman Sachs VP – who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio – is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio."
How to camouflage a factory of 53,000 workers
"If I Had To Pour Every Single Penny of My Retirement Into Just ONE STOCK..." The former Goldman Sachs VP – who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio – is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio."
GRI Bio Announces Pricing Of $5.5 Mln Public Offering, Stock Down
Why Is GRI Bio (GRI) Stock Down 21% Today?
GRI Bio, Inc.: GRI Bio Announces Reverse Stock Split
GRI Bio Announces Reverse Stock Split
GRI Bio Inc GRI
See More Headlines
Receive GRI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GRI Bio and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/23/2024
Next Earnings (Estimated)
5/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:GRI
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

Net Income
$-13,040,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
0.40 per share

Miscellaneous

Free Float
2,659,000
Market Cap
$1.43 million
Optionable
Not Optionable
Beta
-1.77
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Dr. W. Marc Hertz Ph.D. (Age 53)
    Co-Founder, CEO, President & Director
    Comp: $842.01k
  • Ms. Leanne M. Kelly (Age 47)
    CFO & Corporate Secretary
    Comp: $550.93k
  • Dr. Vipin Kumar Chaturvedi Ph.D. (Age 64)
    Co-Founder & Chief Scientific Officer
  • Dr. Albert Agro Ph.d. (Age 59)
    Chief Medical Officer

GRI Stock Analysis - Frequently Asked Questions

How have GRI shares performed in 2024?

GRI Bio's stock was trading at 2.70 at the start of the year. Since then, GRI stock has decreased by 83.4% and is now trading at 0.45.
View the best growth stocks for 2024 here
.

Are investors shorting GRI Bio?

GRI Bio saw a drop in short interest in March. As of March 31st, there was short interest totaling 54,200 shares, a drop of 53.2% from the March 15th total of 115,700 shares. Based on an average daily volume of 716,800 shares, the days-to-cover ratio is currently 0.1 days. Approximately 1.8% of the shares of the company are short sold.
View GRI Bio's Short Interest
.

When is GRI Bio's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our GRI earnings forecast
.

When did GRI Bio's stock split?

GRI Bio shares reverse split on the morning of Tuesday, January 30th 2024. The 1-7 reverse split was announced on Tuesday, January 30th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, January 30th 2024. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

How do I buy shares of GRI Bio?

Shares of GRI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GRI) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners